-
-
-
-
-
-
-
Abbott Labs (ABT) PT Raised to $158 at UBS
-
-
-
-
-
-
-
UBS on why it's still not ready to push the buy button on pharma stocks
-
-
-
-
-
-
-
Abbott (ABT) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY25 EPS Guidance
-
-
-
-
-
-
-
Medtech Q1 earnings preview: Potential tariff exposure
-
-
-
-
-
-
-
Futures slip, U.S. chip restrictions, earnings ahead - what's moving markets
-
-
-
-
-
-
-
Abbott Hosts Conference Call for Fourth-Quarter Earnings
-
-
-
-
-
-
-
Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

